Video: Superheroes, Secret Identities & You | Webinar: ACR/CHEST ILD Guidelines in Practice

Search results for: chronic pain

Drug Updates

Michele B. Kaufman, PharmD, BCGP | May 1, 2010

Information on New Approvals and Medication Safety

Falls Prevention in Vancouver: Is It Time to Advise Our Athletes to Play It Safe?

David S. Pisetsky, MD, PhD | May 1, 2010

Is it time to advise our athletes to play it safe?

Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2010

Information on New Approvals and Medication Safety

Letters to the Editor: Feedback from the Readers

Staff | March 1, 2010

No Such Thing as Fibromyalgia

Drug Updates

Michele Kaufman, PharmD, CGP, RPh | November 1, 2009

Information on News Approvals and Medication Safety

Neurological Piece of the Fibromyalgia Puzzle

Daniel J. Clauw, MD | November 1, 2009

Exploring the peripheral and central elements of pain in FM

Drug Updates

Michele B. Kaufman, PharmD, BCGP | May 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Fibromyalgia

Staff | February 1, 2009

Patient Fact Sheet

Glucocorticoid-Induced Osteoporosis

Staff | June 1, 2008

Osteoporosis is a condition of weak bone caused by a loss of bone mass and a change in bone structure. Glucocorticoid-induced osteoporosis is a form of osteoporosis caused by taking glucocorticoid medications, such as prednisone (Deltasone, Orasone, etc.), prednisolone (Prelone), dexamethasone (Decadron, Hexadrol), and cortisone (Cortone Acetate). These medications are used to help control many rheumatic diseases, including RA, systemic lupus erythematosus, and polymyalgia rheumatica.